Results 111 to 120 of about 9,601 (224)

Muscle Ultrasound in Inclusion Body Myositis: Integrating Qualitative and Quantitative Approaches With Clinical and MRI Findings

Muscle &Nerve, Volume 74, Issue 1, Page 131-138, July 2026.
ABSTRACT Introduction/Aims Inclusion body myositis (IBM) is an inflammatory myopathy with an insidious onset, often making diagnosis challenging. Although neuroimaging has recently been included in diagnostic criteria, the role of muscle ultrasound—despite being a rapid and cost‐effective tool—in IBM has been less extensively characterized.
Giuseppe Di Pietro, Pietro Falco, Rocco Costanzo, Eleonora Galosi, Gianfranco De Stefano, Enrico Evangelisti, Antonio Lauletta, Caterina Leone, Daniel Litewczuk, Giulia Di Stefano, Andrea Truini, Matteo Garibaldi   +11 more
wiley   +1 more source

The Molecular Diagnosis of Myopathies: Integrating Genomic, Proteomic, and Pathological Insights Toward Precision Medicine

Clinical Genetics, Volume 110, Issue 1, Page 15-28, July 2026.
Advances in genomic, proteomic, and transcriptomic technologies are transforming the diagnosis of genetic myopathies. When integrated with traditional muscle pathology, multi‐omics approaches improve diagnostic yield, clarify disease mechanisms, and support more precise, mechanism‐based therapeutic strategies for patients with neuromuscular disorders ...
Ludmila Alem, Denise de Abreu Pereira, Katia Carneiro   +2 more
wiley   +1 more source

Update on Treatment of Inclusion Body Myositis

, 2013
Degenerative mechanisms such as protein accumulation and vacuolar transformation in the skeletal muscle distinguish inclusion body myositis (IBM) from other inflammatory myopathies.
Schmidt, Jens, Breithaupt, Maren
core   +1 more source

Hypertransaminasemia Is a Marker of Severity in Children Hospitalized for Influenza

Influenza and Other Respiratory Viruses, Volume 20, Issue 7, July 2026.
ABSTRACT Purpose Elevated transaminases have been associated with increased severity in adult influenza cases, but data in the pediatric population are limited. This study aims to evaluate the prevalence, clinical characteristics and prognostic value of elevated transaminases in children hospitalized for influenza.
Marco Poeta, Cristina Moracas, Elisabetta Venturini, Sofia Sgubbi, Maria Sole Valentino, Laura Folgori, Laura Petrarca, Claudio Cafagno, Marco Maglione, Anna Cascone, Claudia Colomba, Alice Romero, Fabio Midulla, Giuseppe Indolfi, Vania Giacomet, Amelia Licari, Luisa Galli, Alfredo Guarino   +17 more
wiley   +1 more source

Current essentials in inflammatory myopathies [PDF]

European Medical Journal Neurology, 2013
Inflammatory myopathies are a heterogeneous group of acquired systemic diseases, which include dermatomyositis (DM), polymyositis (PM), necrotising myopathy (NM) and inclusion body myositis (IBM).
Maren Breithaupt, Jens Schmidt
doaj  

Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.

, 2004
Pathologicalprion protein (PrP(Sc)) is the hallmark of prion diseases affecting primarily the central nervous system. Using immunohistochemistry, paraffin-embedded tissue blot, and Western blot, we demonstrated abundant PrP(Sc) in the muscle of a patient
Aguzzi, A., Glatzel, M, Araujo, AQC, Lindeck-Pozza, E., Thomas Ströbel, Gabbai, A A, Adriano Aguzzi, Kovacs, G G, Chimelli, L, Gabbai, Alberto Alain [UNIFESP], Elisabeth Lindeck‐Pozza, Lindeck-Pozza, E, Strobel, T., Gabbai, A. A., Gabor G. Kovacs, Markus Glatzel, Chimelli, L. C., Pozza, E. L., Glatzel, M., Chimelli, L., Ströbel, T, Araújo, A. Q. C., Aguzzi, A; https://orcid.org/, Alberto A. Gabbai, Herbert Budka, Budka, H, Abelardo Q. C. Araújo, Araújo, A Q C, Kovacs, G. G., Budka, H., Leila Chimelli   +30 more
core   +1 more source

Inclusion body myositis: Current pathogenetic concepts and diagnostic and therapeutic approaches

, 2007
Inclusion body myositis is the most common acquired muscle disease in older individuals, and its prevalence varies among countries and ethnic groups. The aetiology and pathogenesis of sporadic inclusion body myositis are still poorly understood; however ...
Mastaglia, F.L., Needham, M.
core  

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis [PDF]

, 2017
\ua9 2017 BMJ Publishing Group Ltd & European League Against Rheumatism. Objectives Autoantibodies directed against cytosolic 50-nucleotidase 1A have been identified in many patients with inclusion body myositis. This retrospective study investigated
Lundberg IE, van Engelen BGM, Benveniste O, Sacconi S, Miller JAL, Hilton-Jones D, Rietveld A, Machado PM, Lecky BRF, Hanna MG, Chinoy H, Gheorghe KR, Roberts ME, Brierley C, Pruijn GJM, Herbert MK, Lamb JA, Saris CGJ, Parton MJ, Badrising UA, McHugh NJ, Pye SR, Lilleker JB, Cooper RG, Mariampillai K, Peeters MTJ   +25 more
core  

Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges

International Journal of General Medicine, 2019
Nika Mohannak,1 Gemma Pattison,2 Kathryn Hird,1 Merrilee Needham1,3,4 1School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia; 2Department of Speech Pathology, Royal Perth Hospital, Perth, Western Australia, Australia ...
Mohannak N, Pattison G, Hird K, Needham M   +3 more
doaj  

Clinical Images: Skin manifestations and radiographic findings of anti‐SAE1 positive dermatomyositis

ACR Open Rheumatology, Volume 8, Issue 7, July 2026.
Amara Seng, George Matcuk, Wonwoo Shon, Lindsy Forbess, Mariko L. Ishimori   +4 more
wiley   +1 more source